>>> US Gapping up

Gapping up
In reaction to earnings/guidance:
  • CVNA +35.1%, ASPN +26.8%, ENVX +22.6% (also reaches development agreement with top 5 smartphone OEM), RSI +16.7%, MAX +14%, CHRW +11%, NOVA +9.1%, UPWK +8.8%, W +8.8%, PTON +8.7%, CAR +8.4%, BHE +8.1%, CRTO +8.1%, HWM +7.9%, HLF +7.6%, SRPT +7.5%, BPMC +7.5%, CORT +7.2%, MGM +6.7%, SWTX +6.7%, MPWR +6.5%, AUPH +6.5%, BHC +6.2%, WRK +6.1%, SSTK +6%, PBF +5.9%, ING +5.8%, BWA +5.7%, ULCC +5.7%, SKWD +5.6%, FORM +5.6%, DLX +5.5%, QCOM +5.5%, GRBK +5.4%, LNTH +5.4%, BTSG +5.2%, NVCR +5.2%, RHP +5.1%, AEIS +5%, MGPI +4.8%, KTB +4.7%, ZBH +4.6%, APTV +4.6%, LAUR +4.5%, BDC +4.5%, OMCL +4.5%, TPB +4.5%, VAL +4.3%, SFM +4.2%, KYMR +4.2%, SEE +4.2%, EXLS +4.1%, LXP +3.9%, CGNX +3.7%, OLPX +3.6%, HST +3.5%, ZTS +3.5%, CNK +3.2%, GERN +3.2%, OGN +3.2%, BDX +3.1%, MCW +3%, SBOW +2.9%, VMC +2.9%, RDN +2.7%, GNW +2.6%, PJT +2.6% (sends additional letter to in regards to short sales violations), CTSH +2.5%, DBD +2.5%, HIPO +2.4%, MT +2.3%, PGRE +2.2%, TTEK +2.2%, CI +2.2%, AIG +2.1% (also increases dividend; announces increases buyback auth by $10 bln), CMPR +2.1%, PBI +2.1%, CTVA +2%, VMI +1.9%, CNHI +1.9%, QTWO +1.8%, MKL +1.6%, BZH +1.6%, EXPI +1.5%, JHG +1.5%, PRDO +1.4%, ALL +1.4%, THRY +1.4%, ALB +1.3%, DVN +1.3%, MRNA +1.3%, SHEL +1.2%, IRM +1.2%, MRO +1.1%, PENN +1.1%, D +1.1%, MTSI +1%
Other news:
  • EBS +57.5% (announces next phase of new operational plan, which consolidates operations, closes several facilities, and restructures its enterprise workforce) INN +7.7% (increases dividend, also reports earnings)
  • IAC +7.3% (to join S&P SmallCap 600)
  • INMB +6.5% (files $250 mln mixed shelf securities offering)
  • BBAI +2.9% (partners with Spinnaker SCA to elevate offering in supply chain consulting)
  • PSTX +2.9% (Poseida Therapeutics and Astellas Pharma (ALPMY) enter into research collaboration and license agreement to develop novel allogeneic cell therapies in oncology)
  • BBIO +2.1% (completion of a $200 mln private financing of its former subsidiary, TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics, to accelerate the development of its oncology portfolio)
  • AMKR +1.5% (files mixed shelf securities offering)
  • BLZE +1.2% (files $200 mln mixed shelf securities offering)
  • CAG +1% (Darren Serrao, Co-COO, to depart; co also will reorganize its reporting structure)
Analyst comments:
  • TTD +3.5% (upgraded to Buy from Hold at Jefferies)
  • SHOP +2.4% (upgraded to Outperform from Underperform at Exane BNP Paribas)
  • SNOW +2.2% (upgraded to Outperform from Neutral at Exane BNP Paribas)
  • BURL +2% (upgraded to Neutral from Sell at UBS)
  • TTMI +1.6% (upgraded to Buy from Hold at Stifel)
  • BFH +1.3% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)
  • SYF +1.2% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)